FI932561A0 - Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning - Google Patents
Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellningInfo
- Publication number
- FI932561A0 FI932561A0 FI932561A FI932561A FI932561A0 FI 932561 A0 FI932561 A0 FI 932561A0 FI 932561 A FI932561 A FI 932561A FI 932561 A FI932561 A FI 932561A FI 932561 A0 FI932561 A0 FI 932561A0
- Authority
- FI
- Finland
- Prior art keywords
- protein
- pharyngeal
- intact epithelium
- variants
- epithelium
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38654—Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90610072 | 1990-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI932561A FI932561A (fi) | 1993-06-04 |
FI932561A0 true FI932561A0 (fi) | 1993-06-04 |
Family
ID=8205875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI932561A FI932561A0 (fi) | 1990-12-05 | 1993-06-04 | Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0561907B1 (fi) |
JP (3) | JP3355186B2 (fi) |
KR (1) | KR100237968B1 (fi) |
AT (1) | ATE170630T1 (fi) |
AU (1) | AU9052891A (fi) |
BR (1) | BR9107206A (fi) |
CA (2) | CA2095852C (fi) |
DE (1) | DE69130113T2 (fi) |
DK (1) | DK0561907T3 (fi) |
FI (1) | FI932561A0 (fi) |
WO (1) | WO1992010755A1 (fi) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL178045B1 (pl) * | 1992-07-17 | 2000-02-29 | Genencor Int | Mutant proteazy do stosowania w detergentach, sekwencja DNA kodująca mutanta proteazy, sposób otrzymywania mutanta proteazy oraz kompozycja detergentowa |
WO1996012186A1 (en) * | 1994-10-14 | 1996-04-25 | Chiron Mimotopes Pty. Ltd. | Method and apparatus for efficient mimotope discovery |
EP1017794A1 (en) | 1997-02-06 | 2000-07-12 | Novo Nordisk A/S | Polypeptide-polymer conjugates having added and/or removed attachment groups |
US6284246B1 (en) | 1997-07-30 | 2001-09-04 | The Procter & Gamble Co. | Modified polypeptides with high activity and reduced allergenicity |
CA2325568A1 (en) | 1998-03-26 | 1999-09-30 | The Procter & Gamble Company | Serine protease variants having amino acid substitutions |
US6908757B1 (en) | 1998-03-26 | 2005-06-21 | The Procter & Gamble Company | Serine protease variants having amino acid deletions and substitutions |
KR20010052223A (ko) * | 1998-03-26 | 2001-06-25 | 데이비드 엠 모이어 | 아미노산 결실 및 치환을 갖는 세린 프로테아제 변이체 |
US6495136B1 (en) | 1998-03-26 | 2002-12-17 | The Procter & Gamble Company | Proteases having modified amino acid sequences conjugated to addition moieties |
US6642011B2 (en) * | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
US6835550B1 (en) | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
US6838269B1 (en) * | 1998-04-15 | 2005-01-04 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6936249B1 (en) | 1998-04-15 | 2005-08-30 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6461849B1 (en) * | 1998-10-13 | 2002-10-08 | Novozymes, A/S | Modified polypeptide |
US6686164B1 (en) | 1998-10-30 | 2004-02-03 | Novozymes A/S | Low allergenic protein variants |
DE69916306T2 (de) * | 1998-10-30 | 2005-05-04 | Novozymes A/S | Niedrigallergene proteinvarianten |
CA2342967A1 (en) * | 1998-12-08 | 2000-06-15 | Biovation Limited | Modifying protein immunogenicity |
EP1206526A2 (en) | 1999-07-22 | 2002-05-22 | The Procter & Gamble Company | Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
US6946128B1 (en) | 1999-07-22 | 2005-09-20 | The Procter & Gamble Company | Protease conjugates having sterically protected epitope regions |
MXPA02000840A (es) * | 1999-07-22 | 2002-07-30 | Procter & Gamble | Variantes de proteasa de subtilisina que tienen substituciones de aminoacidos en regiones de epitopes definidas. |
EP1196546A2 (en) * | 1999-07-22 | 2002-04-17 | The Procter & Gamble Company | Intramolecularly cross-linked subtilisin proteases having reduced immunogenicity |
CN1372593A (zh) * | 1999-07-22 | 2002-10-02 | 宝洁公司 | 具有空间保护的表位区域的蛋白酶缀合物 |
KR20020021395A (ko) | 1999-07-22 | 2002-03-20 | 데이비드 엠 모이어 | 입체적으로 보호된 clip 부위를 갖는 프로테아제콘쥬게이트 |
AU2001254623A1 (en) * | 2000-04-28 | 2001-11-12 | Novozymes A/S | Production and use of protein variants having modified immunogenicity |
PL366249A1 (en) | 2000-07-28 | 2005-01-24 | Henkel Kommanditgesellschaft Auf Aktien | Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
WO2002040997A2 (en) * | 2000-10-02 | 2002-05-23 | Genencor International, Inc. | Production and use of proteins producing an altered immunogenic response |
US6673580B2 (en) * | 2000-10-27 | 2004-01-06 | Genentech, Inc. | Identification and modification of immunodominant epitopes in polypeptides |
ZA200305980B (en) * | 2001-02-12 | 2007-01-31 | Res Dev Foundation | Modified proteins, designer toxins, and methods of making thereof |
EP1373296B1 (en) * | 2001-03-23 | 2011-10-05 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
WO2002079415A2 (en) | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
JP2005501546A (ja) * | 2001-09-04 | 2005-01-20 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 修飾されたヒト成長ホルモン |
JP2005514026A (ja) * | 2001-12-31 | 2005-05-19 | ジェネンコー・インターナショナル・インク | 免疫反応の変化を生じるプロテアーゼ、ならびにその製造および利用方法 |
CA2472206C (en) * | 2001-12-31 | 2013-04-09 | Genencor International, Inc. | Proteases producing an altered immunogenic response and methods of making and using the same |
CN101177675B (zh) | 2002-02-08 | 2014-05-21 | 诺维信公司 | 肌醇六磷酸酶变体 |
WO2003096869A2 (en) * | 2002-05-16 | 2003-11-27 | Alk Abelló A/S | Recombinant bet. v. 1. allergen mutants, methods and process thereof |
KR101211445B1 (ko) | 2002-07-30 | 2012-12-12 | 다니스코 유에스 인크. | 에어로졸 발생을 감소시킨 제형물 |
US20040121953A1 (en) * | 2002-08-09 | 2004-06-24 | Chirino Arthur J. | Thrombopoiesis-stimulating proteins having reduced immunogenicity |
ATE494368T1 (de) | 2002-10-01 | 2011-01-15 | Novozymes As | Polypeptide der gh-61-familie |
WO2004078960A1 (en) | 2003-02-26 | 2004-09-16 | Genencor International, Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
EP2500423B1 (en) | 2003-02-26 | 2015-06-17 | Danisco US Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
DK1639107T3 (da) | 2003-06-19 | 2013-11-18 | Novozymes As | Forbedrede proteaser og fremgangsmåder til fremstilling deraf |
CN1809634A (zh) | 2003-06-19 | 2006-07-26 | 诺维信公司 | 蛋白酶 |
CA2539693A1 (en) | 2003-10-10 | 2005-04-21 | Novozymes A/S | Protease variants |
WO2005040220A1 (en) | 2003-10-16 | 2005-05-06 | Micromet Ag | Multispecific deimmunized cd3-binders |
WO2005066339A2 (en) | 2004-01-06 | 2005-07-21 | Novozymes A/S | Polypeptides of alicyclobacillus sp. |
AU2005206277B2 (en) | 2004-01-22 | 2011-06-23 | Merck Patent Gmbh | Anti-cancer antibodies with reduced complement fixation |
DE602005025202D1 (de) | 2004-04-02 | 2011-01-20 | Novozymes As | Subtilasevarianten mit veränderter immunogenität |
CN101014704A (zh) | 2004-06-21 | 2007-08-08 | 诺维信公司 | 蛋白酶 |
WO2006037327A2 (en) | 2004-10-04 | 2006-04-13 | Novozymes A/S | Polypeptides having phytase activity and polynucleotides encoding same |
AR050895A1 (es) | 2004-10-04 | 2006-11-29 | Novozymes As | Polipeptidos que tienen actividad de fitasa y polinucleotidos que los codifican |
US8119387B2 (en) | 2005-08-16 | 2012-02-21 | Novozymes A/S | Polypeptides of strain Bacillus sp. P203 |
CA2625440C (en) | 2005-10-11 | 2023-06-13 | Micromet Ag | Compositions comprising cross-species-specific antibodies and uses thereof |
EP1960517A2 (en) | 2005-12-06 | 2008-08-27 | Genencor International, Inc. | Perhydrolase epitopes |
ZA200805400B (en) | 2005-12-21 | 2009-09-30 | Micromet Ag | Pharmaceutical compositions with resistance to soluble CEA |
PT1966245E (pt) | 2005-12-30 | 2011-08-31 | Merck Patent Gmbh | Anticorpos anti-cd19 com imunogenicidade reduzida |
ES2384055T3 (es) | 2005-12-30 | 2012-06-28 | Merck Patent Gmbh | Variantes de la interleucina-12p40 con estabilidad mejorada |
US7883711B2 (en) | 2006-03-22 | 2011-02-08 | Novozymes A/S | Use of polypeptides having antimicrobial activity |
BRPI0709732B1 (pt) | 2006-04-04 | 2017-06-06 | Novozymes As | fitase, sequência de ácidos nucleicos isolada, construção de ácido nucleico, vetor de expressão recombinante, microrganismo recombinante, método para produzir a fitase, composição, método para melhorar o valor nutritivo de uma ração para animal, processo para reduzir os níveis de fitato no esterco de animal, método para o tratamento de proteínas de legume, e, uso da fitase ou da composição na ração para animal |
BRPI0721103A2 (pt) | 2006-12-21 | 2014-03-04 | Novozymes As | Lipase, método de determinação do desempenho da digestão in vitro de uma lipase em comparação com uma lipase de referência, uso de uma lipase ou de uma mistura de lipases, composição farmacêutica, e, método para o tratamento de doença |
US8221743B2 (en) | 2006-12-22 | 2012-07-17 | Novozymes A/S | Use of polypeptides against diseases caused by protozoans |
CA2681392C (en) | 2007-03-26 | 2017-08-01 | Novozymes A/S | Hafnia phytase |
EP2933329B1 (en) | 2008-09-26 | 2017-05-17 | Novozymes A/S | Hafnia phytase variants |
JP5781501B2 (ja) | 2009-04-22 | 2015-09-24 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 改変されたFcRn結合部位を有する抗体融合タンパク質 |
JP5822841B2 (ja) | 2009-11-05 | 2015-11-24 | テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド | 変異型のkrasまたはbraf遺伝子を含むがんの治療 |
WO2012119989A2 (en) | 2011-03-04 | 2012-09-13 | Oryzon Genomics, S.A. | Methods and antibodies for the diagnosis and treatment of cancer |
WO2016087514A1 (en) | 2014-12-02 | 2016-06-09 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Anti-mutant calreticulin antibodies and their use in the diagnosis and therapy of myeloid malignancies |
JP2023537982A (ja) | 2020-08-13 | 2023-09-06 | ノボザイムス アクティーゼルスカブ | フィターゼ変異体及びそれをコードするポリヌクレオチド |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3903068A (en) * | 1972-12-26 | 1975-09-02 | Us Health Education & Welfare | Facile synthesis of human insulin by modification of porcine insulin |
DK6488D0 (da) * | 1988-01-07 | 1988-01-07 | Novo Industri As | Enzymer |
DK316989D0 (da) * | 1989-06-26 | 1989-06-26 | Novo Nordisk As | Enzymer |
-
1991
- 1991-12-05 DE DE69130113T patent/DE69130113T2/de not_active Revoked
- 1991-12-05 DK DK92900779T patent/DK0561907T3/da active
- 1991-12-05 AT AT92900779T patent/ATE170630T1/de not_active IP Right Cessation
- 1991-12-05 CA CA002095852A patent/CA2095852C/en not_active Expired - Lifetime
- 1991-12-05 BR BR919107206A patent/BR9107206A/pt not_active IP Right Cessation
- 1991-12-05 CA CA002331936A patent/CA2331936C/en not_active Expired - Lifetime
- 1991-12-05 AU AU90528/91A patent/AU9052891A/en not_active Abandoned
- 1991-12-05 KR KR1019930701690A patent/KR100237968B1/ko not_active IP Right Cessation
- 1991-12-05 EP EP92900779A patent/EP0561907B1/en not_active Revoked
- 1991-12-05 WO PCT/DK1991/000382 patent/WO1992010755A1/en active IP Right Grant
- 1991-12-05 JP JP50164192A patent/JP3355186B2/ja not_active Expired - Lifetime
-
1993
- 1993-06-04 FI FI932561A patent/FI932561A0/fi not_active Application Discontinuation
-
2001
- 2001-07-16 JP JP2001215943A patent/JP3450840B2/ja not_active Expired - Lifetime
-
2002
- 2002-12-04 JP JP2002352804A patent/JP2003174871A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2095852C (en) | 2001-05-08 |
AU9052891A (en) | 1992-07-08 |
WO1992010755A1 (en) | 1992-06-25 |
KR930703610A (ko) | 1993-11-30 |
CA2095852A1 (en) | 1992-06-06 |
EP0561907B1 (en) | 1998-09-02 |
ATE170630T1 (de) | 1998-09-15 |
FI932561A (fi) | 1993-06-04 |
DE69130113D1 (de) | 1998-10-08 |
KR100237968B1 (ko) | 2000-01-15 |
CA2331936C (en) | 2007-07-31 |
JP2003174871A (ja) | 2003-06-24 |
JP3355186B2 (ja) | 2002-12-09 |
DE69130113T2 (de) | 1999-05-12 |
JPH06502994A (ja) | 1994-04-07 |
DK0561907T3 (da) | 1999-05-31 |
EP0561907A1 (en) | 1993-09-29 |
BR9107206A (pt) | 1993-11-03 |
JP3450840B2 (ja) | 2003-09-29 |
CA2331936A1 (en) | 1992-06-06 |
JP2002101880A (ja) | 2002-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI932561A0 (fi) | Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning | |
FI941199A0 (fi) | Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset | |
DE69021002D1 (de) | Schimärische Hepadnavirus-Kernantigenproteine. | |
BR9500732B8 (pt) | Kit diagnóstico para a detecção de anticorpos contra vírus que causam imunodeficiência. | |
PT97159A (pt) | Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina | |
ATE68826T1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
ES2013328A6 (es) | Un metodo para detectar anticuerpos contra antigenos hiv-1. | |
FI931393A (fi) | Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus | |
BG97123A (bg) | Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа | |
CA2178635A1 (en) | Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form | |
FR2692282B1 (fr) | Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications. | |
FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
NO900758D0 (no) | Fremgangsmaate for fremstilling av hybridprotein. | |
DK0471718T3 (da) | Paracetamolholdigt farmaceutisk præparat | |
FR2624854B1 (fr) | Nouveaux sulfonamides du benzylidene camphre derivant d'aminoacides et leur application en cosmetique, notamment en tant que filtres solaires | |
PT87857A (pt) | Process for the preparation of novel immunossupressant peptides | |
DK13087D0 (da) | Gensekvens til fremstilling af human serumalbumin i bacillus | |
NO881942L (no) | Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten. | |
DE68925995D1 (de) | Glasreinigerzusammensetzung | |
DE68922896D1 (de) | RHOPTRY-MEMBRAN-ANTIGEN VON -i(PLASMODIUM FALCIPARUM). | |
ATE175357T1 (de) | Empfängnisverhütender impfstoff | |
ITFI920071A0 (it) | Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vogeesndk | |
NO881779D0 (no) | Fremstilling av l-fenylalanin med hjelp av rekombinante bakterier. | |
FR2363603A1 (fr) | Compositions de polyterephtalate d'alkylene et d'ester sulfonique, cristallisant rapidement | |
IT8620596V0 (it) | Lenti sovrapponibili per variare l'intensita' dell'assorbimento di luce degli occhiali. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused | ||
FCK | Appeal rejected |
Free format text: APPLICATION REJECTED |